Clinical Trial Update: Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast Cancer [NA]

View source ↗

Summary

Clinical trial update announcing ongoing recruitment for a study assessing molecular residual disease in a diverse population of patients with early-stage breas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Breast Cancer, Lymph Node Metastasis | NA | Status: RECRUITING